Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (141-150 of 311) with videos related to

Pageof 32
Sort By:
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignanciesStefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalitiesDeborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Head & Neck|June 5, 2015
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapyAurora Mirabile, Chiara Vismara, Fulvio Crippa, et al.
Cells|August 7, 2020
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant LesionsAndrea Carenzo, Mara S Serafini, Elisa Roca, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experienceMauro Palazzi, Ester Orlandi, Paolo Bossi, et al.
Studies in Health Technology and Informatics|August 10, 2012
Evicase: an evidence-based case structuring approach for personalized healthcareBoaz Carmeli, Paolo Casali, Anna Goldbraich, et al.
Expert Opinion on Investigational Drugs|March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
Frontiers in Oncology|February 3, 2023
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patientsStefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, et al.
Frontiers in Genetics|March 30, 2026
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencingMarica Ficorilli, Marta Lucchetta, Deborah Lenoci, et al.
Translational Oncology|September 17, 2008
TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland CarcinomaTiziana Negri, Elena Tamborini, Gian Paolo Dagrada, et al.
Pageof 32

Showing results (141-150 of 311) with videos related to

Sort By:
Pageof 32
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignanciesStefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalitiesDeborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Head & Neck|June 5, 2015
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapyAurora Mirabile, Chiara Vismara, Fulvio Crippa, et al.
Cells|August 7, 2020
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant LesionsAndrea Carenzo, Mara S Serafini, Elisa Roca, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experienceMauro Palazzi, Ester Orlandi, Paolo Bossi, et al.
Studies in Health Technology and Informatics|August 10, 2012
Evicase: an evidence-based case structuring approach for personalized healthcareBoaz Carmeli, Paolo Casali, Anna Goldbraich, et al.
Expert Opinion on Investigational Drugs|March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
Frontiers in Oncology|February 3, 2023
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patientsStefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, et al.
Frontiers in Genetics|March 30, 2026
Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencingMarica Ficorilli, Marta Lucchetta, Deborah Lenoci, et al.
Translational Oncology|September 17, 2008
TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland CarcinomaTiziana Negri, Elena Tamborini, Gian Paolo Dagrada, et al.
Pageof 32